Clinical Trial Update: Early Treatment of Language Impairment in Young Children With Autism Spectrum Disorder With Leucovorin Calcium [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating leucovorin calcium for early treatment of language impairment in young children with autism spectrum disorder; currently recru…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autism Spectrum Disorder
• Language Disorder

Drugs mentioned

• Leucovorin calcium (calcium folinate)

Snippet

Sponsor: Southwest Autism Research & Resource Center | Conditions: Autism Spectrum Disorder, Language Disorders | Phase 2 | Status: RECRUITING